Postmarketing surveillance of medications and pregnancy outcomes: Clarithromycin and birth malformations
- 1 December 2000
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 9 (7) , 549-556
- https://doi.org/10.1002/pds.538
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Drugs in PregnancyNew England Journal of Medicine, 1998
- The New Antiepileptic Drugs and Women: Efficacy, Reproductive Health, Pregnancy, and Fetal OutcomeEpilepsia, 1996
- Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastineThe American Journal of Cardiology, 1994
- Therapeutic drugs in early pregnancy and congenital defectsJournal of Clinical Epidemiology, 1994
- Women in Clinical Trials of New Drugs -- A Change in Food and Drug Administration PolicyNew England Journal of Medicine, 1993
- The comparative efficacy and safety of clarithromycin and amoxycillin in the treatment of outpatients with acute maxillary sinusitisJournal of Antimicrobial Chemotherapy, 1991
- A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumoniaJournal of Antimicrobial Chemotherapy, 1991
- The development of macrolides: clarithromycin in perspectiveJournal of Antimicrobial Chemotherapy, 1991
- USE OF MEDICAID DATA FOR PHARMACOEPIDEMIOLOGYAmerican Journal of Epidemiology, 1989
- ON THE ABILITY OF BIRTH DEFECTS MONITORING TO DETECT NEW TERATOGENSAmerican Journal of Epidemiology, 1987